- Home
- NXRT vs PSNL Comparison
NXRT vs PSNL Comparison
Compare NXRT & PSNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NXRT | PSNL |
|---|---|---|
| Founded | 2014 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical Specialities |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 617.2M | 729.1M |
| IPO Year | 2014 | 2019 |
Fundamental Metrics
Financial Performance| Metric | NXRT | PSNL |
|---|---|---|
| Price | $28.98 | $5.91 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 4 | 5 |
| Target Price | ★ $31.00 | $12.20 |
| AVG Volume (30 Days) | 153.3K | ★ 1.8M |
| Earning Date | 04-28-2026 | 05-07-2026 |
| Dividend Yield | ★ 7.50% | N/A |
| EPS Growth | N/A | ★ 33.58 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $251,281,000.00 | $69,648,000.00 |
| Revenue This Year | $3.09 | $15.34 |
| Revenue Next Year | $3.02 | $41.46 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $23.79 | $3.84 |
| 52 Week High | $38.08 | $11.50 |
Technical Indicators
Market Signals| Indicator | NXRT | PSNL |
|---|---|---|
| Relative Strength Index (RSI) | 66.30 | 43.29 |
| Support Level | $27.69 | $5.81 |
| Resistance Level | $32.12 | $6.99 |
| Average True Range (ATR) | 0.82 | 0.43 |
| MACD | 0.35 | -0.00 |
| Stochastic Oscillator | 89.06 | 43.17 |
Price Performance
Historical ComparisonAbout NXRT NexPoint Residential Trust Inc.
NexPoint Residential Trust Inc is a real estate investment trust company. The trust's objectives are to maximize the cash flow and value of properties owned, acquire properties with cash flow growth potential, provide quarterly cash distributions, and achieve long-term capital appreciation for stockholders. It focuses on acquiring multifamily properties in markets with attractive job growth and household formation fundamentals predominantly in the Southeastern and Southwestern United States. The company generates revenue from the rental of multifamily properties.
About PSNL Personalis Inc.
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.